Pancreatic islets of bank vole show signs of dysfunction after prolonged exposure to high glucose concentrations in vitro.
Bank voles develop glucose intolerance/diabetes mellitus when kept in captivity. We have characterized beta-cell function of glucose intolerant/diabetic animals, and found that this animal model has features of both human type 1 and type 2 diabetes. The aim of this study was to study the functional alterations of islets isolated from glucose tolerant bank voles after a prolonged exposure to various glucose concentrations in vitro. For this purpose, pancreatic islets from normal (glucose tolerant) male and female bank voles were cultured at different glucose concentrations (5.6, 11.1 (control), or 28 mM) whereupon islet functions were examined. Overall, islet insulin output was lowered at 5.6 mM glucose, and similar to control, or enhanced after culture in 28 mM glucose. High glucose culture led to decreased insulin contents, but there was no change in islet DNA content and in morphological assessments of cell death, with the latter findings suggesting that the so-called glucotoxicity had not evolved. A slight gender difference was observed in that islets isolated from females exhibited a glucose-regulated (pro)insulin biosynthesis rate and insulin gene expression. In conclusion, we have found that islets isolated from female and male bank voles are affected by glucose concentrations in vitro in that some signs of dysfunction were observed upon high glucose exposure. A minor gender difference was observed suggesting that the islets of the females may more readily adapt to the elevated glucose concentration than islets of the male bank voles. It could be that these in vitro gender differences observed may represent a mechanism underlying the gender difference in diabetes development observed among bank voles.
Blixt
Martin
M
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. martin.blixt@mcb.uu.se
Niklasson
Bo
B
Sandler
Stellan
S
D000818:Animals; D003411:Arvicolinae / Q000502:physiology*; D002470:Cell Survival; D002478:Cells, Cultured; D003470:Culture Media / Q000032:analysis; D004247:DNA / Q000032:analysis; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D007328:Insulin / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology*; D008297:Male; D009994:Osmolar Concentration; D010084:Oxidation-Reduction; D011384:Proinsulin / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D012727:Sex Characteristics
D003470:Culture Media; D007328:Insulin; D012333:RNA, Messenger; D004247:DNA; D011384:Proinsulin; D005947:Glucose